BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2010
View Archived Issues
Sanofi-aventis reports Q4 and full-year results for 2009
Read More
Matrix Laboratories claims new TRPV1 receptor antagonists as analgesics
Read More
TopoTarget describes new nicotinamide phosphoribosyltransferase inhibitors
Read More
Organon and Pharmacopeia disclose novel LXR ligands
Read More
Leo Pharma presents novel VEGFR-2 inhibitors
Read More
Novel SMO receptor antagonists described by Italian researchers
Read More
Tekmira provides corporate update and results 2009
Read More
Otilonium bromide improves irritable bowel syndrome symptoms
Read More
ONCOFID-P-B well tolerated and active in phase I trial in refractory bladder carcinoma
Read More
Data on OX1/OX2 orexin receptor antagonist MK-4305 presented at ACS Meeting
Read More
Colestilan monotherapy improves glycemic and cholesterolemic control in type 2 diabetes
Read More
First-in-human clinical data on Mttp inhibitor JNJ-16269110 presented at ASCPT meeting
Read More
Preclinical data on new GlyT-1 inhibitor RG-1678 presented at ACS meeting
Read More
Novavax reports on 2009 A/H1N1 VLP pandemic flu vaccine
Read More
EMA accepts Cinryze MAA for hereditary angioedema for filing
Read More
ChemGenex provides update on regulatory status of Omapro
Read More
Aastrom treats final patient in phase IIb RESTORE-CLI trial of vascular repair cells
Read More
Arena begins phase I trial of APD-916 for narcolepsy and cataplexy
Read More
Poniard redirects regulatory efforts for picoplatin
Read More
Othera reports phase I/II data on OT-551 in age-related macular degeneration
Read More
Vernalis announces topline phase IIb results on V-3381 for neuropathic pain in diabetes
Read More
Preliminary phase IIb data on Sativex in cancer pain support entry into phase III
Read More
Human Genome Sciences reports interim phase IIb results on Zalbin in hepatitis C
Read More
FDA orphan drug designation for Diamyd's rhGAD65 in type 1 diabetes with residual beta-cell function
Read More
Salix's Xifaxan approved in U.S. for reducing risk of overt hepatic encephalopathy recurrence
Read More